Zantac Linked To Cause Cancer

November 24, 2020 / 9:11 am

Heartburn is a tragedy. It creeps up on you and then hits like a freight train. Typically people know what triggers their heartburn, but you have to learn the hard way—by eating something you love and then feeling the after-effects. When you google heartburn relief, you will find drugs like Nexium, Pepcid, or Prilosec. What you don’t see is what was one of the most popular heartburn drugs: Zantac.

Our successful Zantac cancer attorneys at Colson Hicks Eidson are very familiar with the story of Zantac. If you or someone you love has developed cancer and took Zantac, we are here to fight for you.

What Happened To Zantac?

In April 2020, the US Food and Drug Administration requested that the manufacturers stop making the prescription and over-the-counter Zantac immediately. The immediate removal was due to an ongoing investigation of a contaminant in the medicine that can cause cancer. The contaminant increases over time if stored in higher-than-normal temperatures.

The contaminant is N-nitrosodimethylamine or NDMA. NDMA is a human carcinogen in which the FDA has been investigating its levels in ranitidine since the summer of 2019. Even though the FDA has stated that the levels have not been significant in the few samples they have tested, the FDA is aware that the mass production needs more attention than just a few samples. This was a highly used drug, and people’s health should be a top priority.

Since the news broke in 2020, top companies like CVS, Walgreens, and Walmart have stopped shelving the Zantac and other over-the-counter ranitidine drugs. Following the major chains refusals to sell the drug, the actual drugmaker Sanofi decided to voluntarily stop the production and selling of Zantac to the US and to Canada. The company stated that the decision to stop the drug’s production and the sale was due to “inconsistencies in preliminary test results.”

Who Do You Believe? Big Pharma?

We get it. There is no one cure-all for any ailment. We live our lives, making the best decisions with the information we have. But this isn’t some mild reaction to a skin cream or getting a fuzzy tongue from eating pineapple; this is cancer. There is scientific evidence showing that Zantac was contaminated with nearly 3,000 times the FDA daily intake limit of NDMA. Your life is in danger, and the company in charge should pay.

What We Can Do

Big pharma is big. Pharmaceutical companies have money, politics, and manpower. But what they don’t have is the truth. Our savvy and deeply dedicated attorneys at Colson Hicks Eidson have successfully attacked big pharma before, and we are doing it again. Our goal is to ensure that you get the compensation you deserve, such as the cost of current and future medical bills, mental anguish damages, recovery of income, loss of enjoyment of life, and any punitive damages against the drug company. If you or a loved one has developed cancer and takes or took Zantac, contact us for a free consultation by clicking here or by calling us at 305-476-7400.

Trending Stories

January 22, 2025

Latest Updates
and Insights from Colson

Related News & Case Studies

MIAMI (January 22, 2025) – Colson Hicks Eidson is thrilled to announce that three of its partners have been named in the 2025 Lawdragon 500 Leading Lawyers in America. This impressive guide selects its lawyers through Lawdragon’s independent journalistic research and submissions process.

Now in its 20th year, Lawdragon 500 Leading Lawyers in America recognized Colson Hicks Eidson attorneys Julie Braman Kane, Roberto Martínez, and Curtis Miner for their exceptional work in litigation, plaintiff class action litigation, and white-collar practice areas.

Julie’s work has made a significant difference in the lives of her clients. She has represented plaintiffs in personal injury, commercial, and class action litigation, participating in cases securing hundreds of millions of dollars for clients, including recent resolutions of a data breach class action as well as multiple personal injury and wrongful death matters.

Curtis has tried cases to jury verdicts against auto manufacturers and airlines and has obtained sizable settlements in individual and plaintiffs’ class action litigation, having served as Class Counsel in cases against financial institutions arising out of Ponzi schemes and as part of court-appointed leadership counsel in the Takata Airbags Products Liability Litigation MDL, securing over $1.5 billion in settlements for classes of millions of vehicle owners.

Roberto has secured significant client wins in high-profile cases, including participating in settlements and judgments totaling in excess of $6 billion.

Click here to read the full guide on Lawdragon.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

A federal judge in Florida denied UnitedHealthcare’s motion to dismiss a lawsuit brought by a cancer patient seeking coverage for proton beam radiation therapy to treat his tongue cancer. The patient, Carlos Morera, alleges the insurer wrongfully denied benefits under his healthcare plan, forcing him to pay approximately $195,000 out of pocket for the treatment.

Stephanie A. Casey, a partner at Colson Hicks Eidson, represents Morera and successfully argued that the case should proceed.

“We look forward to presenting the merits of this case at trial. Proton beam radiation therapy has long been recognized as the standard of care for these types of cancers,” she said.

The court’s decision allows Morera to continue his fight to recover treatment costs. Read more about this case on Law360 here.

MIAMI (November 20, 2024) – Colson Hicks Eidson has been named to the 2025 edition of the “Best Law Firms” by Best Lawyers®, recognized at both the national and metropolitan levels. Seven of the firm’s attorneys were also named to the 2025 edition of Best Lawyers® across multiple practice areas.

“We are committed to delivering exceptional representation for our clients. This continued recognition of our firm’s core practice areas highlights the success of our efforts,” said Dean C. Colson, Managing Partner of Colson Hicks Eidson.

Best Lawyers® ranks top lawyers and law firms through a peer review process, using feedback from lawyers, clients, and professional references, along with firm data. Rankings are organized into regional and national tiers.

National Tier 2

● Mass Tort Litigation / Class Actions – Plaintiffs

Metropolitan Tier 1

Miami

● Bet-the-Company Litigation
● Commercial Litigation
● Criminal Defense: White-Collar
● Insurance Law
● Mass Tort Litigation / Class Actions – Plaintiffs
● Medical Malpractice Law – Defendants
● Medical Malpractice Law – Plaintiffs
● Personal Injury Litigation – Plaintiffs
● Product Liability Litigation – Plaintiffs

Metropolitan Tier 2

Miami

● Professional Malpractice Law – Defendants

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

MIAMI (November 12, 2024) – Colson Hicks Eidson announced today that managing partner Dean Colson has been recognized in Florida Trend’s 2024 edition of the Florida 500, a publication highlighting the 500 most influential executives across various economic sectors in the state.

The publication notes that Dean’s credentials include chairing the state university system’s Board of Governors, the board of trustees for Florida International University, and the board of trustees for the University of Miami.

Dean is renowned as a top trial lawyer in the U.S. with 40 years of experience in complex civil litigation, personal injury, product liability, and professional malpractice. He has successfully represented large plaintiff classes and handled multimillion-dollar cases, including high-profile litigation such as the AeroPeru airplane crash and a Ponzi scheme settlement.

Dean has demonstrated a strong commitment to community service through various leadership roles. He has been actively involved with the Institute of Contemporary Art in Miami, supporting access to the arts. He’s also been president of the Orange Bowl Committee and chaired the Super Bowl XXIX Host Committee. He served on the Florida Commission on Ethics and chaired the Florida Supreme Court Judicial Nominating Commission. He previously served as President of the Dade County Bar Association and as a distinguished member of the Florida Bar Board of Governors. Most recently, the Coral Gables Community Foundation recognized Dean at its 2024 Annual Gala with the Education Award.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication to forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

The U.S. Attorney’s Office for the Southern District of Florida has launched a new Whistleblower Non-Prosecution Pilot Program. It reinforces the recent efforts of the Department of Justice Criminal Division’s new Corporate Whistleblower Awards Pilot Program.

The local pilot program offers non-prosecution agreements in exchange for the early and voluntary self-disclosures of criminal conduct.  The Department’s pilot program offers financial rewards to a whistleblower who provides original and truthful information about corporate misconduct that results in a successful forfeiture.  

Both pilot programs require the prompt disclosure of truthful and complete information.   

At Colson Hicks Eidson, our attorneys have advised and represented clients across the full range of internal investigations, government inquiries, enforcement actions, whistleblower actions, and civil and criminal trials.  For further information, contact us at 305-476-7400 or info@colson.com.

MIAMI (June 24, 2024) – Colson Hicks Eidson announced today that six of its attorneys have been named in the 2024 edition of Florida Super Lawyers. Stephanie Casey, Dean Colson, Joseph J. Kalbac, Jr., Julie Braman Kane, and Curtis Miner have been named Super Lawyers. Zachary Lipshultz has been recognized as a Rising Star.

Super Lawyers uses a rigorous screening process including independent research, peer nominations, and evaluations to rate lawyers. Only 5 percent of lawyers in Florida are rated by Super Lawyers, and no more than 2.5 percent of lawyers under 40 or with fewer than 10 years of practice are selected as Rising Stars.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.